Literature DB >> 6108989

Activity of erythrocyte Na,K-ATPase in manic patients.

K Akagawa, M Watanabe, Y Tsukada.   

Abstract

Erythrocyte membrane Na,K-ATPase activity of manic patients was studied. The activity of patients in acute manic phase was higher than that of normal controls, while that of patients in normal phase was not. Even in the same patient, the activity in acute phase was higher than that in normal phase. Mg-ATPase activities did not differ between controls and patients. These findings clearly indicate a possible correlation between change in clinical phase in manic patients and change of erythrocyte membrane Na,K-ATPase activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6108989     DOI: 10.1111/j.1471-4159.1980.tb12513.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  4 in total

1.  Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission.

Authors:  Kathleen Askland; Cynthia Read; Jason Moore
Journal:  Hum Genet       Date:  2008-12-04       Impact factor: 4.132

2.  Pharmacodynamics and pharmacokinetics of digoxin in the presence of lithium.

Authors:  S J Cooper; J G Kelly; G D Johnston; S Copeland; D J King; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

3.  Imipramine Can Be Effective on Depressive-Like Behaviors, but Not on Neurotrophic Factor Levels in an Animal Model for Bipolar Disorder Induced by Ouabain.

Authors:  Taise Possamai-Della; Gustavo C Dal-Pont; Wilson R Resende; Jorge M Aguiar-Geraldo; Jefté Peper-Nascimento; João Quevedo; Samira S Valvassori
Journal:  Mol Neurobiol       Date:  2022-09-19       Impact factor: 5.682

4.  Erythrocyte membrane sodium-potassium adenosine triphosphatase activity in affective disorders.

Authors:  P L Reddy; S Khanna; M N Subhash; S M Channabasavanna; B S Rao
Journal:  J Neural Transm Gen Sect       Date:  1992
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.